Future Perspectives: Key Trends Shaping the Intravenous Therapy Solutions Market Up to 2030

Intravenous therapy solutions are becoming increasingly vital in healthcare, offering critical support in various medical treatments. As the demand for more efficient, personalized, and technologically integrated care grows, this market is set to experience remarkable expansion in the coming years. Let's explore the current market size, key drivers, major companies, prevailing trends, and detailed segmentation shaping the intravenous therapy solutions sector.

Projected Expansion of the Intravenous Therapy Solutions Market by 2030
The intravenous therapy solutions market is projected to grow significantly, reaching $21.25 billion by 2030. This represents a compound annual growth rate (CAGR) of 10.0% during the forecast period. The anticipated growth stems from several factors, including the rising adoption of home healthcare, increasing demand for personalized nutrition and precise medication delivery, integration with digital health platforms, expansion in emerging markets, and heightened focus on managing chronic diseases. Key trends expected to influence the market include customizable IV therapy options, development of portable and home-use IV devices, improved infection control and safety measures, advancements in electrolyte and nutrient formulations, and enhanced compatibility with electronic health records (EHR).

Download a free sample of the intravenous therapy solutions market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25802&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR

Leading Corporations Driving the Intravenous Therapy Solutions Industry
The market features several prominent players contributing to its development and innovation. These include Pfizer Inc., Otsuka Pharmaceutical Co. Ltd., Baxter International Inc., Fresenius Kabi AG, Grifols S.A., Terumo Corporation, Dr. Reddy's Laboratories Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Hikma Pharmaceuticals PLC, Biocon Limited, B. Braun Melsungen Aktiengesellschaft, JW Life Science Corporation, AdvaCare Pharma USA, Soxa Formulations & Research Pvt. Ltd., Vifor Pharma Management Ltd., Aetos Pharma Private Limited, LXIR Medilabs Private Limited, Amanta Healthcare Limited, Aculife Healthcare Private Limited, Claris Lifesciences Limited, Osel Lifesciences Pvt. Ltd., and BBraun Avitum AG.

Significant Acquisition Expanding Immunology Portfolio
In April 2025, US-based healthcare firm Organon & Co. acquired the regulatory and commercial rights to Tofidence from Biogen Inc. This strategic move aims to bolster Organon & Co.'s US biosimilars immunology portfolio by incorporating Tofidence, which supports the treatment of multiple arthritis indications and COVID-19. Organon & Co. plans to leverage its commercial expertise and market access capabilities to foster long-term growth in the immunology sector. Biogen Inc. is a biotechnology company specializing in intravenous therapy solutions, including Tofidence.

View the full intravenous therapy solutions market report:
https://www.thebusinessresearchcompany.com/report/intravenous-therapy-solutions-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR

Emerging Trends Enhancing Efficiency in Intravenous Therapy Solutions
Many leading companies in the intravenous therapy solutions market are innovating with ready-to-use drug infusion products to improve treatment efficiency and minimize preparation time in clinical settings. Ready-to-use drug infusion refers to pre-prepared, standardized IV medications that come pre-mixed and labeled, eliminating the need for on-site compounding or dilution.

A notable example occurred in May 2024 when B. Braun Medical Inc., a US-based manufacturer, launched Levetiracetam in Sodium Chloride Injection, a ready-to-use intravenous anticonvulsant designed for seizure treatment. This product is available in standardized concentrations and volumes, removing the necessity for dilution or compounding at the point of care. The formulation comes pre-mixed in a flexible container, ensuring precise dosing, reducing contamination risks, and enhancing convenience for healthcare providers in emergency and inpatient environments.

Detailed Market Segmentation of the Global Intravenous Therapy Solutions Industry
This report divides the intravenous therapy solutions market into several key segments:

1) Product Type: Crystalloids, Colloids, Blood Products, and Other Product Types
2) Application: Fluid and Electrolyte Imbalance, Nutritional Support, Medication Administration, Blood Transfusion, and Other Applications
3) End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, and Other End-Users

Further subcategories include:
- Crystalloids: Normal Saline (0.9% Sodium Chloride), Half Normal Saline (0.45% Sodium Chloride), Lactated Ringer's Solution, Dextrose Solutions, Hypertonic Saline
- Colloids: Albumin, Dextran, Hydroxyethyl Starch (HES), Gelatin
- Blood Products: Packed Red Blood Cells (PRBCs), Platelets, Fresh Frozen Plasma (FFP), Cryoprecipitate
- Other Product Types: Intravenous Immunoglobulins (IVIG), Parenteral Nutrition Solutions, Specialty Intravenous Drugs and Additives

This segmentation provides a comprehensive view of the market's breadth and the specialized options available to meet diverse patient needs across various healthcare settings.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.